Us Market

India-US lane feeling pricing squeeze: TVS Supply Chain Solutions MD

TVS SCS MD Ravi Viswanathan outlines growth plans, US market deals, margin improvement and how restructuring and outsourcing trends will shape the company's next phase

Investors grow cautious as lowest-rated US junk bonds show renewed strain

Spreads between US investment-grade bonds and junk have widened over the last week, signalling that investors are favouring safer bonds instead of high-yield notes

Glenmark Pharma to launch Ropivacaine Hydrochloride Injection USP in US

The product is approved as bioequivalent and therapeutically equivalent to the reference listed drug, Naropin Injection, marketed by Fresenius Kabi USA LLC

US SEC chief vows to fast-track plan to end quarterly results reporting

Trump floated the idea of jettisoning quarterly reporting earlier this month, though it wasn't the first time he'd proposed such an idea

US market brings highest returns for Tata Electronics' iPhone shipments

Apple's move to expand iPhone production in India boosted Tata Electronics' revenue, with shipments to the US alone contributing the largest share in the last financial year

Trump supporters' bid to block IT outsourcing puts jobs, growth at risk

Trump's possible move to block US companies from outsourcing IT work to India threatens a $282 bn industry, risking jobs, exports, and tech delivery models

WinZO announces launch in the US, expanding international footprint

WinZO officially launches in the US after a successful entry into Brazil, aiming to solidify its position in the global gaming market, valued at $65-70 billion with over 20 billion downloads annually

Stock market close highlights: Sensex down 368pts, Nifty at 24,487; Financial, FMCG top drags

Stock Market Close Highlights, August 12, 2025: The BSE Sensex settled 368.49 points or 0.46 per cent lower at 80,235.59 levels, while Nifty50 ended 97.65 points or 0.4 per cent lower at 24,487.40.

Poly Medicure to invest ₹500 cr in new plants for global market push

Poly Medicure to set up three plants in Faridabad, Haridwar, and Jaipur for dialysis, cardiology, and oncology devices, targeting US, Europe, and Brazil markets by FY28

Stock market close highlights: Sensex up 746pts, Nifty at 24,585; PSU Bk, Auto, Realty stocks shine

Stock market close highlights on Monday, August 11, 2025: On the BSE, Tata Motors, Eternal and Trent were the top gainers while ICICI Bank, BEL and Bharti Airtel were among the major laggards.

Limited US access to hit India's manufacturing growth plans, says Moody's

Moody's Ratings on Monday said curtailed access to the US market will diminish prospects for India to develop its manufacturing sector, but the country's domestic demand will remain resilient to these external pressures. US President Donald Trump has announced a 25 per cent duty on imports from India, which will come into effect from August 7 (9.30 am IST). These will be over and above the existing standard import duty in the United States. On top of the import duty, Trump has announced imposing a 'penalty' on India for Russian imports. However, the rate of penalty is yet to be announced. Moody's Ratings, Senior Vice President, Christian de Guzman said the revised tariff rate assessed on Indian goods is significantly above those from other major exporters in the APAC (Asia-Pacific) region, many of which have duty rates between 15 per cent and 20 per cent. "Curtailed access to the largest economy globally diminishes prospects for India's ambitions to develop its manufacturing sector

Sun Pharma, Lupin, Dr Reddy's recall products in US due to mfg issues

Domestic drug majors Sun Pharma, Lupin and Dr Reddy's Laboratories are recalling drugs in the US market due to manufacturing issues and product mix up, according to the US health regulator. As per the latest Enforcement Report of US Food and Drug Administration (USFDA), the Mumbai-headquartered Sun Pharmaceutical Industries is recalling 5,448 bottles of a generic medication in the US. Princeton-based Sun Pharmaceutical Industries Inc is recalling the affected lot of Lisdexamfetamine Dimesylate capsules (60 mg) due to "Failed Dissolution Specifications", the US health regulator stated. The medication is used to treat attention deficit hyperactivity disorder (ADHD). The drug firm initiated the Class II recall in the US on June 16 this year, it added. Another Mumbai-based drug maker Lupin is recalling 58,968 bottles of a generic combination medication used to treat high blood pressure. Naples-based Lupin Pharmaceuticals Inc is recalling Lisinopril and Hydrochlorothiazide tablets (US

Nvidia hits $4 trn market cap; first company ever to reach the milestone

Just a day after President Donald Trump escalated his trade rhetoric, investors awaited tariff announcements for a number of countries

Lupin launches nasal spray in US, part of 200-drug pipeline by FY30

The product, launched in the US market, is a generic version of Atrovent and part of Lupin's plan to scale complex generics revenue share to 62 per cent by FY30

GENIUS Act & Stablecoins: A turning point for crypto? | Cryptocurrency | US market | US Dollar

The US Senate on june 18, passed the GENIUS Act, a landmark bill that aims to regulate stablecoins, the type of cryptocurrency that’s pegged to the US dollar.

Trump's plans to cut drug prices in US may impact Indian pharma landscape

Trump's executive order, dated May 12, seeks to establish a mechanism through which American patients can buy their drugs directly from the manufacturers

Dr Reddy's Q4 results: Profit rises 22% to ₹1,594 crore on record revenue

Dr Reddy's posts highest-ever quarterly revenue and profit in Q4 FY25 with strong growth in generics, PSAI and NRT acquisition; FY25 PAT up 2 per cent at ₹5,654 crore

Trump's Fed criticism rattles markets; US stocks dip, dollar hits 3-yr low

Safe-haven gold prices hit another record high, while the Swiss franc also rose. Benchmark US Treasury yields edged higher

From Ray-Bans to wigs, American buyers may see unexpected price hikes

During Trump's first term when he imposed much more limited tariffs on China, many companies reported they lacked pricing power to pass on costs to consumers

Rubber makers brace for cuts in output as Türkiye may gain edge in US mkt

Farmers' groups brace to fight against impact on growers